Brii Biosciences Limited
HKEX:2137.HK
1.07 (HKD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 11.078 | 11.078 | 8.113 | 8.113 | 20.049 | 20.049 | 47.197 | 47.197 | 13.943 | 13.943 | 23.441 | 23.441 | 22.83 | 22.83 | 30.557 | 30.557 | 10.553 | 10.553 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | -19.351 | 0 | 10.731 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 11.078 | 11.078 | 8.113 | 8.113 | 39.399 | 20.049 | 36.466 | 47.197 | 13.943 | 13.943 | 23.441 | 23.441 | 22.83 | 22.83 | 30.557 | 30.557 | 10.553 | 10.553 |
| Gross Profit Ratio
| 1 | 1 | 1 | 1 | 1.965 | 1 | 0.773 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 63.085 | 63.085 | 100.265 | 100.265 | 101.088 | 101.088 | 91.075 | 91.075 | 129.242 | 129.242 | 168.502 | 168.502 | 78.806 | 78.806 | 305.027 | 305.027 | 132.871 | 132.871 |
| General & Administrative Expenses
| 39.315 | 39.315 | 46.838 | 46.838 | 51.412 | 51.412 | 36.581 | 36.581 | 47.734 | 47.734 | 70.207 | 70.207 | 33.995 | 33.995 | 31.115 | 31.115 | 20.583 | 20.583 |
| Selling & Marketing Expenses
| 16.478 | 16.478 | 0.02 | 0.02 | 0.69 | 0.69 | 5.743 | 5.743 | 7.688 | 7.688 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 55.793 | 55.793 | 46.858 | 46.858 | 52.102 | 52.102 | 42.324 | 42.324 | 55.422 | 55.422 | 70.207 | 70.207 | 33.995 | 33.995 | 31.115 | 31.115 | 20.583 | 20.583 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 118.877 | 118.877 | 147.123 | 32.585 | 141.526 | 141.526 | 122.526 | 122.526 | 201.681 | 201.681 | 644.988 | 644.988 | 1,499.483 | 1,499.483 | 518.109 | 518.109 | 165.125 | 165.125 |
| Operating Income
| -107.8 | -107.8 | -139.01 | -139.01 | -133.141 | -133.141 | -86.202 | -86.202 | -170.721 | -170.721 | -215.268 | -215.268 | -89.971 | -89.971 | -305.585 | -305.585 | -142.902 | -142.902 |
| Operating Income Ratio
| -9.731 | -9.731 | -17.135 | -17.135 | -6.641 | -6.641 | -1.826 | -1.826 | -12.245 | -12.245 | -9.183 | -9.183 | -3.941 | -3.941 | -10.001 | -10.001 | -13.542 | -13.542 |
| Total Other Income Expenses Net
| -33.82 | -33.82 | 145.238 | 145.238 | 34.728 | 34.728 | 24.118 | 24.118 | -12.086 | -12.086 | -403.485 | -403.485 | -1,386.819 | -1,386.819 | -182.056 | -182.056 | -11.213 | -11.213 |
| Income Before Tax
| -141.619 | -141.619 | 6.228 | 6.228 | -98.413 | -98.413 | -62.084 | -62.084 | -182.807 | -182.807 | -618.753 | -618.753 | -1,476.79 | -1,476.79 | -487.641 | -487.641 | -154.114 | -154.114 |
| Income Before Tax Ratio
| -12.784 | -12.784 | 0.768 | 0.768 | -4.909 | -4.909 | -1.315 | -1.315 | -13.111 | -13.111 | -26.396 | -26.396 | -64.686 | -64.686 | -15.959 | -15.959 | -14.605 | -14.605 |
| Income Tax Expense
| -1.352 | -1.352 | -1.316 | -1.316 | -7.814 | -3.455 | 14.091 | 6.279 | -9.014 | -9.014 | -13.417 | -13.417 | -0.201 | -0.201 | -46.956 | -46.956 | 0.001 | 0.001 |
| Net Income
| -140.268 | -140.268 | 7.544 | 7.544 | -94.959 | -94.959 | -68.363 | -68.363 | -173.794 | -173.794 | -605.336 | -605.336 | -1,476.589 | -1,476.589 | -440.686 | -440.686 | -154.115 | -154.115 |
| Net Income Ratio
| -12.662 | -12.662 | 0.93 | 0.93 | -4.736 | -4.736 | -1.448 | -1.448 | -12.465 | -12.465 | -25.824 | -25.824 | -64.678 | -64.678 | -14.422 | -14.422 | -14.605 | -14.605 |
| EPS
| -0.19 | -0.19 | 0.01 | 0.01 | -0.13 | -0.13 | -0.094 | -0.094 | -0.24 | -0.24 | -0.89 | -0.89 | -7.43 | -7.43 | -2.27 | -2.27 | -0.82 | -0.82 |
| EPS Diluted
| -0.19 | -0.19 | 0.01 | 0.01 | -0.13 | -0.13 | -0.094 | -0.094 | -0.24 | -0.24 | -0.89 | -0.89 | -7.43 | -7.43 | -2.27 | -2.27 | -0.82 | -0.82 |
| EBITDA
| -106.64 | -106.64 | -137.602 | -137.602 | -131.054 | -131.054 | -84.014 | -84.014 | -168.735 | -168.735 | -213.316 | -213.316 | -88.084 | -88.084 | -303.699 | -303.699 | -141.695 | -141.695 |
| EBITDA Ratio
| -9.627 | -9.627 | -16.962 | -16.962 | -6.537 | -6.537 | -1.78 | -1.78 | -12.102 | -12.102 | -9.1 | -9.1 | -3.858 | -3.858 | -9.939 | -9.939 | -13.428 | -13.428 |